Thompson Siegel & Walmsley’s Adtran ADTN Stock Holding History

Thompson Siegel & Walmsley’s Portfolio ADTN Stock Details ADTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-35,559	Closed	-$296K	–	386
2024 Q4	$296K	Buy	+35,559	New	+$263K	﹤0.01%	355

Other funds holding ADTN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return

DCM

Divisar Capital Management San Francisco, California $392M AUM 108.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Thompson Siegel & Walmsley's ADTN Position: Q1 2025 in Review

Thompson Siegel & Walmsley sold out of Adtran (ADTN) in Q1 2025, closing a stake of 35,559 shares — an estimated $296K sold.

Thompson Siegel & Walmsley first reported a position in ADTN in Q4 2024 and held it in 1 quarter. The position peaked at $296K in Q4 2024. 205 funds tracked by Wall St. Rank hold ADTN as of Q1 2025.

Thompson Siegel & Walmsley reported no remaining Adtran position as of Q1 2025 after selling out during the quarter.
Thompson Siegel & Walmsley sold 35,559 Adtran shares in Q1 2025, an estimated $296K.
Thompson Siegel & Walmsley first reported a position in Adtran in Q4 2024 and held it in 1 quarter.
Thompson Siegel & Walmsley's Adtran position peaked at $296K in Q4 2024.
205 funds tracked by Wall St. Rank held Adtran as of Q1 2025.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2025, filed 9 May 2025.